Importer of Controlled Substances Application: Cambrex Charles City, 43603-43604 [2020-15464]
Download as PDF
43603
Federal Register / Vol. 85, No. 138 / Friday, July 17, 2020 / Notices
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–626 and 731–
TA–1452 (Final)]
Certain Collated Steel Staples From
China
Determinations
On the basis of the record 1 developed
in the subject investigations, the United
States International Trade Commission
(‘‘Commission’’) determines, pursuant
to the Tariff Act of 1930 (‘‘the Act’’),
that an industry in the United States is
materially injured by reason of imports
of certain collated steel staples from
China, provided for in subheading
8305.20.0000 of the Harmonized Tariff
Schedule of the United States, that have
been found by the U.S. Department of
Commerce (‘‘Commerce’’) to be sold in
the United States at less than fair value
(‘‘LTFV’’), and to be subsidized by the
government of China.2
Background
khammond on DSKJM1Z7X2PROD with NOTICES
The Commission instituted these
investigations effective June 6, 2019,
following receipt of petitions filed with
the Commission and Commerce by
Kyocera Senco Industrial Tools, Inc.
(‘‘Senco’’), Cincinnati, Ohio. The final
phase of the investigations was
scheduled by the Commission following
notification of preliminary
determinations by Commerce that
imports of certain collated steel staples
from China were subsidized within the
meaning of section 703(b) of the Act (19
U.S.C. 1671b(b)) and sold at LTFV
within the meaning of 733(b) of the Act
(19 U.S.C. 1673b(b)). Notice of the
scheduling of the final phase of the
Commission’s investigations and of a
public hearing to be held in connection
therewith was given by posting copies
of the notice in the Office of the
Secretary, U.S. International Trade
Commission, Washington, DC, and by
publishing the notice in the Federal
Register on January 21, 2020 (85 FR
3417). In light of the restrictions on
access to the Commission building due
to the COVID–19 pandemic, and in
accordance with 19 U.S.C. 1677c(a)(1),
the Commission conducted its hearing
via video conference on May 27, 2020;
all persons who requested the
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
2 The Commission also finds that imports subject
to Commerce’s affirmative critical circumstances
determination are not likely to undermine seriously
the remedial effect of the countervailing and
antidumping duty orders on certain collated steel
staples from China.
VerDate Sep<11>2014
18:12 Jul 16, 2020
Jkt 250001
opportunity were permitted to
participate.
The Commission made these
determinations pursuant to sections
705(b) and 735(b) of the Act (19 U.S.C.
1671d(b) and 19 U.S.C. 1673d(b)). It
completed and filed its determinations
in these investigations on July 13, 2020.
The views of the Commission are
contained in USITC Publication 5085
(July 2020), entitled Certain Collated
Steel Staples from China: Investigation
Nos. 701–TA–626 and 731–TA–1452
(Final).
By order of the Commission.
Issued: July 13, 2020.
Lisa Barton,
Secretary to the Commission.
following basic class(es) of a controlled
substance:
Controlled substance
Methcathinone ..........................
Drug
code
Schedule
1237
I
The company plans to import the
listed controlled substance for
distribution of analytical reference
standards to its customers for analytical
testing of raw materials. No other
activities for this drug code are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–15465 Filed 7–16–20; 8:45 am]
BILLING CODE P
[FR Doc. 2020–15457 Filed 7–16–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–669]
[Docket No. DEA–682]
Importer of Controlled Substances
Application: Cambrex Charles City
Importer of Controlled Substances
Application: United States
Pharmacopeial Convention
ACTION:
Notice of application.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 17, 2020. Such persons
may also file a written request for a
hearing on the application on or before
August 17, 2020.
DATES:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 17, 2020. Such persons
may also file a written request for a
hearing on the application on or before
August 17, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on June 17, 2020, United
States Pharmacopeial Convention, 7135
English Muffin Way, Frederick,
Maryland 21704, applied to be
registered as an importer of the
DATES:
ACTION:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on May 6, 2020, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616, applied to be
registered as an importer of the
following basic class(es) of controlled
substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\17JYN1.SGM
17JYN1
43604
Federal Register / Vol. 85, No. 138 / Friday, July 17, 2020 / Notices
Controlled substance
4-Anilino-N-phenethyl-4-piperidine (ANPP).
Phenylacetone ..........................
Coca Leaves .............................
Opium, raw ...............................
Poppy Straw Concentrate .........
Drug
code
Schedule
8333
II
8501
9040
9600
9670
II
II
II
II
The company plans to import the
listed controlled substances for internal
use and to manufacture bulk
intermediates for sale to its customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–15464 Filed 7–16–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1125–NEW]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested; Certification
and Release of Records
Executive Office for
Immigration Review, Department of
Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Executive Office for Immigration
Review (EOIR), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
September 15, 2020.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Lauren Alder Reid, Assistant Director,
Office of Policy, Executive Office for
Immigration Review, 5107 Leesburg
Pike, Suite 2500, Falls Church, VA
22041, telephone: (703) 305–0289.
Written comments and/or suggestions
can also be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20530 or sent
to OIRA_submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:23 Jul 16, 2020
Jkt 250001
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and/or
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
New Optional Collection.
2. The Title of the Form/Collection:
Certification and Release of Records.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form EOIR–59. The applicable
component within the Department of
Justice is the Office of the General
Counsel, Executive Office for
Immigration Review.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Individuals.
Other: None.
Abstract: This information collection
is necessary to prevent unauthorized
disclosure of records of individuals
maintained by the Department of
Justice, and allows parties who are, or
were, in proceedings before EOIR to
disclose or release their records to an
attorney, accredited representative,
qualified organization, or other third
party.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that there are
50,596 respondents, 50,596 annual
responses, and that each response takes
10 minutes to complete.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated public burden
associated with this collection is 8,433
hours. It is estimated that respondents
will take 10 minutes to complete a
questionnaire. The burden hours for
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
collecting respondent data sum to 8,433
hours (50,596 respondents × 10 minutes
per response = 8,433 hours).
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405B,
Washington, DC 20530.
Dated: July 14, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2020–15462 Filed 7–16–20; 8:45 am]
BILLING CODE 4410–30–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Water
Act
On July 13, 2020, the Department of
Justice lodged a proposed consent
decree with the United States District
Court for the District of New Hampshire
in the lawsuit entitled United States of
America v. City of Manchester, New
Hampshire, Civil Action No. 20–cv–762.
The United States’ Complaint alleges
violations of the Clean Water Act and
the City of Manchester’s National
Pollutant Discharge Elimination System
Permit. The claims arise from the City’s
combined sewer overflows which have
resulted in the discharge of pollutants
from the City’s wastewater collection
system. The Consent Decree calls for an
approximately twenty year program of
improvements which will result in the
City eliminating or capturing for
treatment 95% of the City’s annual wet
weather combined sewage.
The publication of this notice opens
a period for public comment on the
consent decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States v. City of Manchester, D.J.
Ref. No. 90–5–1–1–11620. All
comments must be submitted no later
than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
E:\FR\FM\17JYN1.SGM
17JYN1
Agencies
[Federal Register Volume 85, Number 138 (Friday, July 17, 2020)]
[Notices]
[Pages 43603-43604]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15464]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-669]
Importer of Controlled Substances Application: Cambrex Charles
City
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before August 17, 2020.
Such persons may also file a written request for a hearing on the
application on or before August 17, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on May 6, 2020, Cambrex Charles City, 1205 11th Street,
Charles City, Iowa 50616, applied to be registered as an importer of
the following basic class(es) of controlled substances:
[[Page 43604]]
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Phenylacetone........................... 8501 II
Coca Leaves............................. 9040 II
Opium, raw.............................. 9600 II
Poppy Straw Concentrate................. 9670 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
internal use and to manufacture bulk intermediates for sale to its
customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-15464 Filed 7-16-20; 8:45 am]
BILLING CODE P